Physician profile
Sergio Ramon
NPI 1407866734
$2,027.99
in general payments reported to CMS, 2019-2025
18 companies · $535 in 2025
The $535 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $39.30 · 2021: $171 · 2022: $302 · 2023: $411 · 2024: $425 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $344.54 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Ironshore Pharmaceuticals INC. | $343.38 | 2019-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $337.35 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $246.73 | 2025 | Jornay Pm |
| Tris Pharma INC | $123.19 | 2021-2025 | Onyda Xr |
| Cranial Technologies, INC | $89.19 | 2021-2024 | Doc Band |
| Supernus Pharmaceuticals, INC. | $81.91 | 2022-2024 | Qelbree |
| Noven Therapeutics, LLC | $73.59 | 2025 | Xelstrym |
| Vertical Pharmaceuticals, LLC | $73.57 | 2019-2025 | Relexxii |
| Takeda Pharmaceuticals U.S.A., INC. | $55.34 | 2020-2021 | |
| Alk-Abello, INC | $53.20 | 2023-2025 | Grastek, Odactra, Ragwitek |
| Corium, LLC | $46.68 | 2022-2023 | Azstarys |
| Shire North American Group INC | $34.25 | 2019 | |
| Pfizer INC. | $31.35 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $27.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $26.88 | 2019 | |
| Verrica Pharmaceuticals INC. | $22.46 | 2024 | Ycanth |
| Azurity Pharmaceuticals, INC. | $17.38 | 2025 | Alvesco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Ramon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.